drugset / Trial / NCT00174746

Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma

NCT00174746

Phase 2 Completed 1145 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the efficacy and safety of ciclesonide inhaled into the lungs in a range of doses in a new dry powder inhaler compared to ciclesonide inhaled into the lungs using a metered dose inhaler

Timeline

Start
2005-03
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciclesonide Other / unclassified Inhaled

Indications